Analysis of adverse reactions' factors to Danhong injection--nested case control study by using hospital centralized monitoring data.
10.19540/j.cnki.cjcmm.20180115.023
- Author:
Meng-Meng JI
1
;
Chun-Xiao LI
2
;
Jin-Fa TANG
2
;
Qing-Li ZHANG
3
;
Tao XU
2
;
Ya-Nan YU
4
;
Jun LIU
4
;
Wei YANG
4
;
Wei-Bin YANG
5
;
Zhong WANG
4
;
Zhi-Wei JING
1
;
Xue-Lin LI
2
Author Information
1. China Academy of Chinese Medical Sciences, Beijing 100700, China.
2. The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou 450000, China.
3. Hospital of National Defense University, Beijing 100091, China.
4. Institute of Basic Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China.
5. Graduate School of China Academy of Chinese Medical Sciences, Beijing 100700, China.
- Publication Type:Journal Article
- Keywords:
Danhong injection;
adverse reaction;
hospital centralized monitoring;
nested case control design study
- From:
China Journal of Chinese Materia Medica
2018;43(8):1714-1719
- CountryChina
- Language:Chinese
-
Abstract:
To study the adverse reactions' factors to Danhong injection in the real world. A multi-center, large sample and prospective hospital centralized monitoring method was adopted, and 30 888 cases of Danhong injection from 37 national 3A hospitals were collected to carry out a nested case control design study. These cases were divided into adverse reaction group and non-adverse group. Single factor logistic regression and multiple factor logistic regression were used to analyze data, and investigate the correlation between adverse reaction and gender, allergy history, methods of administration, and combined drug use. One hundred and eight cases of adverse reactions in 30 888 patients were determined, with an incidence of 0.35%. The results showed that Danhong injection combined with other medication(potassium mendoxine magnesium, thymic peptide, celecoxib, fumarate bisoprolol) with history of adverse reactions including scephalosporin allergy and proprietary Chinese medicine allergies had more adverse reactions than the control group(<0.05, estimated coefficient>0), indicating that these six factors were the risk factors for the adverse reaction of Danhong injection. The adverse reaction of Danhong injection combined with the aspirin was less than that in the control group(<0.05, estimated coefficient<0), indicating that the aspirin was a non-risk factor for the adverse reaction of Danhong injection. All the above results indicate that the adverse factors to Danhong injection include scephalosporin allergy, patent Chinese medicine allergy, Danhong injection combined with medication(potassium mendoxine magnesium, thymic peptide, celecoxib, fumarate bisoprolol), suggesting special attention shall be paid in clinical application.
